Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)
Top Cited Papers
Open Access
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 133 (2), 500-510.e11
- https://doi.org/10.1016/j.jaci.2013.12.1037
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Oral Immunotherapy for Treatment of Egg Allergy in ChildrenNew England Journal of Medicine, 2012
- Extrathymically generated regulatory T cells control mucosal TH2 inflammationNature, 2012
- Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumabMucosal Immunology, 2012
- Type 1 regulatory T cells (Tr1) in autoimmunitySeminars in Immunology, 2011
- Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergyJournal of Allergy and Clinical Immunology, 2011
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic responseJournal of Allergy and Clinical Immunology, 2011
- Clinical efficacy and immune regulation with peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2009
- Induction of antigen-specific regulatory T cells in wild-type mice: Visualization and targets of suppressionProceedings of the National Academy of Sciences, 2008
- Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expressionNature Protocols, 2006
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003